Literature DB >> 3003973

HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III.

M H Sayers, P G Beatty, J A Hansen.   

Abstract

15,680 volunteer blood donors were screened by enzyme-linked immunosorbent assay (EIA) for antibodies to human T-lymphotropic virus Type III (HTLV-III). On at least two of three determinations, 0.37 percent were found to be reactive. When the first 38 of these samples were sent for repeat EIA and Western blot, the EIA was positive in 14. In only three of these 14 samples was the EIA result confirmed by Western blot. Eight of these eleven false-positive samples were from women who were found to have HLA antibodies. In seven of these women, the HLA antibodies were directed to Class II antigens expressed on the cell used to grow HTLV-III in the preparation of screening EIA kits. We conclude that HLA antibodies are an important cause of false-positive reactions in the screening test for HTLV-III antibody.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003973     DOI: 10.1046/j.1537-2995.1986.26186124012.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

3.  Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus.

Authors:  P Portincasa; G Conti; M Gerloni; C Chezzi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

4.  Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2.

Authors:  L Gonzalez; R W Boyle; M Zhang; J Castillo; S Whittier; P Della-Latta; L M Clarke; J R George; X Fang; J G Wang; B Hosein; C Y Wang
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.

Authors:  V L Ng; C S Chiang; C Debouck; M S McGrath; T H Grove; J Mills
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 6.  Transfusion-associated acquired immunodeficiency syndrome.

Authors:  T A Peterman
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 7.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

8.  Evaluation of the Genetic Systems Corp. Integra HIV-1 Pageblot system.

Authors:  C A Starkey; B Yen-Lieberman; M R Proffitt
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting.

Authors:  J Blomberg; P J Klasse
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.